Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

63.35 +0.80 (+1.28%)
Official Closing Price Updated: 7:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,443,509
Open 63.81
Bid (Size) 54.80 (7)
Ask (Size) 54.82 (14)
Prev. Close 62.55
Today's Range 62.30 - 65.59
52wk Range 13.47 - 72.98
Shares Outstanding 191,922,517
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64. 
Via Benzinga
Topics Stocks
Hims & Hers Tumbles After-Hours On Q2 Miss, GLP-1 Slowdown — But Retail Traders Eye Bargain Entry
Via Stocktwits

Performance

YTD
+151.4%
+151.4%
1 Month
+30.8%
+30.8%
3 Month
+51.3%
+51.3%
6 Month
+62.7%
+62.7%
1 Year
+255.1%
+255.1%

More News

Read More
Hims & Hers (HIMS) Q2 Revenue Jumps 73%
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Monday?
Via Chartmill
Earnings Scheduled For August 4, 2025
Via Benzinga
Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%
Via StockStory
Hims & Hers Health Stock Tumbles On Q2 Earnings As Revenue Comes Up Short, Company Sees 'Exciting Period Of Growth' Ahead
Via Benzinga
IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss
Via Investor's Business Daily
Topics ETFs Earnings
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
This Biotech Stock Could Soar on Upcoming Clinical Data
Via The Motley Fool
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
Via The Motley Fool
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)
Via NewMediaWire
Topics Fraud Lawsuit
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)
Via TheNewswire.com
Topics Fraud Lawsuit
What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings
Via StockStory
Topics Artificial Intelligence Economy World Trade
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
Will Hims & Hers Fall Along With Novo Nordisk?
Via MarketBeat
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
Via Benzinga
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS
Via NewMediaWire
Topics Fraud Lawsuit

Frequently Asked Questions

Is Hims & Hers Health, Inc. Class A Common Stock publicly traded?
Yes, Hims & Hers Health, Inc. Class A Common Stock is publicly traded.
What exchange does Hims & Hers Health, Inc. Class A Common Stock trade on?
Hims & Hers Health, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Hims & Hers Health, Inc. Class A Common Stock?
The ticker symbol for Hims & Hers Health, Inc. Class A Common Stock is HIMS on the New York Stock Exchange
What is the current price of Hims & Hers Health, Inc. Class A Common Stock?
The current price of Hims & Hers Health, Inc. Class A Common Stock is 63.35
When was Hims & Hers Health, Inc. Class A Common Stock last traded?
The last trade of Hims & Hers Health, Inc. Class A Common Stock was at 08/04/25 07:00 PM ET
What is the market capitalization of Hims & Hers Health, Inc. Class A Common Stock?
The market capitalization of Hims & Hers Health, Inc. Class A Common Stock is 12.16B
How many shares of Hims & Hers Health, Inc. Class A Common Stock are outstanding?
Hims & Hers Health, Inc. Class A Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.